Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage

Richard A. Lang, Donald Metcalf, R. Andrew Cuthbertson, Ian Lyons, Ed Stanley, Anne Kelso, George Kannourakis, D. James Williamson, Gordon K. Klintworth, Thomas J. Gonda, Ashley R. Dunn

Research output: Contribution to journalArticlepeer-review

319 Scopus citations

Abstract

Transgenic mice carrying the murine granulocyte-macrophage colony stimulating factor (GM-CSF) gene expressed from a retroviral promoter exhibit elevated levels of GM-CSF in the serum, urine, peritoneal cavity, and eye. The eyes of transgenic mice are opaque, contain accumulations of macrophages, and develop retinal damage. Similarly, lesions containing macrophages develop in striated muscle. The mice also display an accumulation of large, often multinucleate, activated macrophages in the peritoneal and pleural cavities. The transgene is transcribed in peritoneal cells, as well as in eyes and infiltrated striated muscle. A high proportion of transgenic mice die with muscle wasting when aged 2-4 months, possibly because of macrophage activation resulting from the high levels of GM-CSF.

Original languageEnglish (US)
Pages (from-to)675-686
Number of pages12
JournalCell
Volume51
Issue number4
DOIs
StatePublished - Nov 20 1987
Externally publishedYes

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage'. Together they form a unique fingerprint.

Cite this